Management of Dyshidrosis
Topical corticosteroids are the first-line treatment for dyshidrosis, with high-potency formulations recommended for acute phases (2-4 weeks) showing excellent clinical response rates of up to 94.1%.
First-Line Treatment Options
Topical Corticosteroids
- Acute phase (2-4 weeks): High-potency topical corticosteroids such as betamethasone dipropionate 1
- Longer treatment periods: Medium-potency corticosteroids 1
- Mild cases: Low-potency corticosteroids 1
Emollient Therapy
- Apply fragrance-free emollients liberally and frequently (3-8 times daily) 1
- Apply immediately after bathing to lock in moisture 1
- Continue even when skin appears normal 1
- Choose formulation based on:
Second-Line Treatment Options
Topical Calcineurin Inhibitors
- Tacrolimus 0.1% ointment shows comparable efficacy to mometasone furoate 0.1% ointment 2
- Particularly useful for rotation therapy with topical corticosteroids in chronic cases 2
- Helps avoid side effects of prolonged corticosteroid use (skin atrophy, telangiectasias, striae) 1
Phototherapy
- Oral PUVA (Psoralen + UVA) has shown superior efficacy to UVB for hand eczema 3
- Oral PUVA demonstrated significant improvement or clearance in 81-86% of patients with hand and foot eczema 3
- Topical PUVA has shown variable results in comparative studies 3
Management Algorithm
Identify and eliminate triggers:
Initial treatment for acute flares:
For chronic or recurrent cases:
For superinfected lesions:
Special Considerations
Refractory Cases
- Consider referral to specialist care for:
- Diagnostic uncertainty
- Failure to respond to appropriate topical treatments
- Need for second-line treatments 1
Prevention of Recurrence
- Consistent use of emollients even during remission periods 1
- Identification and avoidance of triggering factors 1
- Consider maintenance therapy with medium-potency corticosteroids or tacrolimus for chronic cases 1, 2
Common Pitfalls and Caveats
Overuse of topical corticosteroids: Limit high-potency corticosteroids to 2-4 weeks to avoid side effects 1
Inadequate emollient use: Insufficient or inconsistent application leads to impaired barrier function and increased flares 1
Missing fungal infections: Dyshidrosis-like eruptions can be caused by fungal infections that require specific antimycotic treatment 4, 5
Neglecting contact allergens: Persistent cases may be due to unidentified contact allergens requiring patch testing 1
Misdiagnosis: Dyshidrosis can present similarly to other conditions like palmoplantar pustulosis or contact dermatitis 4
Dyshidrosis often follows a chronic relapsing course, requiring a long-term management strategy that balances effective treatment with minimizing side effects from prolonged therapy.